Preclinical evidence and possible mechanisms of β-asarone for rats and mice with Alzheimer’s disease: A systematic review and meta-analysis

Background: Currently, there are many different drugs to improve Alzheimer’s disease (AD) from different pathways. As a supplement and alternative medicine, traditional Chinese medicine (TCM) targets multiple pathways which may be different from classical Western medicine, which may be orchestrated...

ver descrição completa

Detalhes bibliográficos

Principais autores:	Xin-Yuan Du, Yu-Shuang Cao, Juan Yang, Li-Chen Guo, Tong Zhang, Qing Yuan, Xi Chen, Li-min Hu
Formato:	Artigo
Idioma:	Inglês
Publicado em:	Frontiers Media S.A. 2022-08-01
Colecção:	Frontiers in Pharmacology
Assuntos:	β-asarone Alzheimer’s disease preclinical evidence mechanisms meta-analysis
Acesso em linha:	https://www.frontiersin.org/articles/10.3389/fphar.2022.956746/full
Tags:	Adicionar Tag Sem tags, seja o primeiro a adicionar uma tag!